Le Joncour V, Guichet PO, Dembélé KP, Mutel A, Campisi D, Perzo N, Desrues L, Modzelewski R, Couraud PO, Honnorat J, Ferracci FX, Marguet F, Laquerrière A, Vera P, Bohn P, Langlois O, Morin F, Gandolfo P, Castel H. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma. Front Cell Dev Biol. 2021 Apr 14 ; 9:652544. doi : 10.3389/fcell.2021.652544 [↗]. eCollection 2021. PMID : 33937253 [↗] ; PMCID: PMC8079989 [↗].
Le Boiteux E, Court F, Guichet PO, Vaurs-Barrière C, Vaillant I, Chautard E, Verrelle P, Costa BM, Karayan-Tapon L, Fogli A, Arnaud P. Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage. Mol Oncol. 2021 Aug ; 15(8):1995-2010. doi : 10.1002/1878-0261.12944 [↗]. Epub 2021 May 2. PMID : 33720519 [↗] ; PMCID: PMC8334257 [↗].
Pelé T, Giraud S, Joffrion S, Ameteau V, Delwail A, Goujon JM, Macchi L, Hauet T, Dkhissi F, Benzakour O. Study of the Role of the Tyrosine Kinase Receptor MerTK in the Development of Kidney Ischemia-Reperfusion Injury in RCS Rats. Int J Mol Sci. 2021 Nov 9 ; 22(22):12103. doi : 10.3390/ijms222212103 [↗]. PMID : 34829984 [↗] ; PMCID : PMC8618874 [↗].
Tachon G, Masliantsev K, Rivet P, Desette A, Milin S, Gueret E, Wager M, Karayan-Tapon L, Guichet PO. MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells. Cancers (Basel). 2021 Nov 25 ; 13(23):5943. doi: 10.3390/cancers13235943 [↗]. PMID : 34885053 [↗] ; PMCID : PMC8672280 [↗].
Recherche clinique & translationnelle
Biau J, Thivat E, Chautard E, Stefan D, Boone M, Chauffert B, Bourgne C, Richard D, Molnar I, Levesque S, Bellini R, Kwiatkowski F, Karayan-Tapon L, Verrelle P, Godfraind C, Durando X. Radiother Oncol. Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma 2021 Jan ; 154:227-234. doi : 10.1016/j.radonc.2020.09.036[↗]. Epub 2020 Sep 22. PMID : 32976869[↗].
Taïeb J, André T, El Hajbi F, Barbier E, Toullec C, Kim S, Bouche O, Di Fiore F, Chauvenet M, Perrier H, Evesque L, Laurent-Puig P, Emile JF, Bez J, Lepage C, Tougeron D. Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. Dig Liver Dis. 2021 Mar ; 53(3):318-323. doi : 10.1016/j.dld.2020.11.031 [↗]. Epub 2020 Dec 25. PMID : 33359404 [↗].
Roussille P, Auvray M, Vansteene D, Lecomte T, Rigault E, Maillet M, Locher C, Dior M, Hautefeuille V, Artru P, Mabro M, Touchefeu Y, Marthey L, Moulin V, Louafi S, Lecaille C, Chautard R, Lièvre A, Zaanan A, Bennouna J, Berger A, Emambux S, Randrian V, Tougeron D. Prognostic factors of colorectal cancer patients with brain metastases. Radiother Oncol. 2021 May ; 158:67-73. doi : 10.1016/j.radonc.2021.02.006 [↗]. Epub 2021 Feb 16. PMID: 33600872 [↗].
Guyot D’Asnières De Salins A, Tachon G, Cohen R, Karayan-Tapon L, Junca A, Frouin E, Godet J, Evrard C, Randrian V, Duval A, Svrcek M, Lascols O, Vignot S, Coulet F, André T, Fléjou JF, Cervera P, Tougeron D. Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer. ESMO Open. 2021 Jun ; 6(3):100120. doi : 10.1016/j.esmoop.2021.100120 [↗]. Epub 2021 Apr 28. PMID: 33930657 [↗] ; PMCID: PMC8102173 [↗].
Metges JP, Genet D, Tougeron D, Ligeza C, Ducreux M, Borg C, Guimbaud R, Phelip JM, Dourthe LM, Kim S. Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort. Future Oncol. 2021 Sep ; 17(25):3343-3353. doi : 10.2217/fon-2021-0266 [↗]. Epub 2021 May 20. PMID : 34011165 [↗].
Randrian V, Evrard C, Tougeron D. Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies. Cancers (Basel). 2021 Jun 19 ; 13(12):3063. doi: 10.3390/cancers13123063 [↗]. PMID: 34205397 [↗] ; PMCID: PMC8235567 [↗]. Review.
Olivier R, Randrian V, Tougeron D, Saurin JC. Endoscopy to Diagnose and Prevent Digestive Cancers in Lynch Syndrome. Cancers (Basel). 2021 Jul 13 ; 13(14):3505. doi : 10.3390/cancers13143505 [↗]. PMID : 34298719 [↗] ; PMCID : PMC8305049 [↗].
Gallois C, Emile JF, Kim S, Monterymard C, Gilabert M, Bez J, Lièvre A, Dahan L, Laurent-Puig P, Mineur L, Coriat R, Legoux JL, Hautefeuille V, Phelip JM, Lecomte T, Sokol H, Capron C, Randrian V, Lepage C, Lomenie N, Kurtz C, Taieb J, Tougeron D. Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial. Dig Liver Dis. 2021 Oct ; 53(10):1254-1259. doi : 10.1016/j.dld.2021.06.009 [↗]. Epub 2021 Jun 30. PMID : 34215534 [↗].
Randrian V, Desette A, Emambux S, Derangere V, Roussille P, Frouin E, Godet J, Karayan-Tapon L, Ghiringhelli F, Tougeron D. New Artificial Intelligence Score and Immune Infiltrates as Prognostic Factors in Colorectal Cancer With Brain Metastases. Front Immunol. 2021 Oct 18 ; 12:750407. doi : 10.3389/fimmu.2021.750407 [↗]. eCollection 2021. PMID : 34733283 [↗] ; PMCID : PMC8558563 [↗].
Koeppel F, Muller E, Harlé A, Guien C, Sujobert P, Trabelsi Grati O, Kosmider O, Miguet L, Mauvieux L, Cayre A, Salgado D, Preudhomme C, Karayan-Tapon L, Tachon G, Coulet F, Lespagnol A, Beroud C, Leroy K, Rouleau E, Soubeyran I. Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies. Eur J Cancer. 2021 Dec ; 159:1-15. doi : 10.1016/j.ejca.2021.08.047 [↗]. Epub 2021 Oct 23. PMID : 34700215 [↗].
